Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome.
<h4>Background</h4>Neurologic Post Treatment Lyme disease (nPTLS) and Chronic Fatigue (CFS) are syndromes of unknown etiology. They share features of fatigue and cognitive dysfunction, making it difficult to differentiate them. Unresolved is whether nPTLS is a subset of CFS.<h4>Met...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-02-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21383843/pdf/?tool=EBI |
| _version_ | 1818435977506455552 |
|---|---|
| author | Steven E Schutzer Thomas E Angel Tao Liu Athena A Schepmoes Therese R Clauss Joshua N Adkins David G Camp Bart K Holland Jonas Bergquist Patricia K Coyle Richard D Smith Brian A Fallon Benjamin H Natelson |
| author_facet | Steven E Schutzer Thomas E Angel Tao Liu Athena A Schepmoes Therese R Clauss Joshua N Adkins David G Camp Bart K Holland Jonas Bergquist Patricia K Coyle Richard D Smith Brian A Fallon Benjamin H Natelson |
| author_sort | Steven E Schutzer |
| collection | DOAJ |
| description | <h4>Background</h4>Neurologic Post Treatment Lyme disease (nPTLS) and Chronic Fatigue (CFS) are syndromes of unknown etiology. They share features of fatigue and cognitive dysfunction, making it difficult to differentiate them. Unresolved is whether nPTLS is a subset of CFS.<h4>Methods and principal findings</h4>Pooled cerebrospinal fluid (CSF) samples from nPTLS patients, CFS patients, and healthy volunteers were comprehensively analyzed using high-resolution mass spectrometry (MS), coupled with immunoaffinity depletion methods to reduce protein-masking by abundant proteins. Individual patient and healthy control CSF samples were analyzed directly employing a MS-based label-free quantitative proteomics approach. We found that both groups, and individuals within the groups, could be distinguished from each other and normals based on their specific CSF proteins (p<0.01). CFS (n = 43) had 2,783 non-redundant proteins, nPTLS (n = 25) contained 2,768 proteins, and healthy normals had 2,630 proteins. Preliminary pathway analysis demonstrated that the data could be useful for hypothesis generation on the pathogenetic mechanisms underlying these two related syndromes.<h4>Conclusions</h4>nPTLS and CFS have distinguishing CSF protein complements. Each condition has a number of CSF proteins that can be useful in providing candidates for future validation studies and insights on the respective mechanisms of pathogenesis. Distinguishing nPTLS and CFS permits more focused study of each condition, and can lead to novel diagnostics and therapeutic interventions. |
| first_indexed | 2024-12-14T17:01:27Z |
| format | Article |
| id | doaj.art-289b8e3f2af942ad86653c771d9bda42 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-14T17:01:27Z |
| publishDate | 2011-02-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-289b8e3f2af942ad86653c771d9bda422022-12-21T22:53:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-02-0162e1728710.1371/journal.pone.0017287Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome.Steven E SchutzerThomas E AngelTao LiuAthena A SchepmoesTherese R ClaussJoshua N AdkinsDavid G CampBart K HollandJonas BergquistPatricia K CoyleRichard D SmithBrian A FallonBenjamin H Natelson<h4>Background</h4>Neurologic Post Treatment Lyme disease (nPTLS) and Chronic Fatigue (CFS) are syndromes of unknown etiology. They share features of fatigue and cognitive dysfunction, making it difficult to differentiate them. Unresolved is whether nPTLS is a subset of CFS.<h4>Methods and principal findings</h4>Pooled cerebrospinal fluid (CSF) samples from nPTLS patients, CFS patients, and healthy volunteers were comprehensively analyzed using high-resolution mass spectrometry (MS), coupled with immunoaffinity depletion methods to reduce protein-masking by abundant proteins. Individual patient and healthy control CSF samples were analyzed directly employing a MS-based label-free quantitative proteomics approach. We found that both groups, and individuals within the groups, could be distinguished from each other and normals based on their specific CSF proteins (p<0.01). CFS (n = 43) had 2,783 non-redundant proteins, nPTLS (n = 25) contained 2,768 proteins, and healthy normals had 2,630 proteins. Preliminary pathway analysis demonstrated that the data could be useful for hypothesis generation on the pathogenetic mechanisms underlying these two related syndromes.<h4>Conclusions</h4>nPTLS and CFS have distinguishing CSF protein complements. Each condition has a number of CSF proteins that can be useful in providing candidates for future validation studies and insights on the respective mechanisms of pathogenesis. Distinguishing nPTLS and CFS permits more focused study of each condition, and can lead to novel diagnostics and therapeutic interventions.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21383843/pdf/?tool=EBI |
| spellingShingle | Steven E Schutzer Thomas E Angel Tao Liu Athena A Schepmoes Therese R Clauss Joshua N Adkins David G Camp Bart K Holland Jonas Bergquist Patricia K Coyle Richard D Smith Brian A Fallon Benjamin H Natelson Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS ONE |
| title | Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. |
| title_full | Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. |
| title_fullStr | Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. |
| title_full_unstemmed | Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. |
| title_short | Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. |
| title_sort | distinct cerebrospinal fluid proteomes differentiate post treatment lyme disease from chronic fatigue syndrome |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21383843/pdf/?tool=EBI |
| work_keys_str_mv | AT steveneschutzer distinctcerebrospinalfluidproteomesdifferentiateposttreatmentlymediseasefromchronicfatiguesyndrome AT thomaseangel distinctcerebrospinalfluidproteomesdifferentiateposttreatmentlymediseasefromchronicfatiguesyndrome AT taoliu distinctcerebrospinalfluidproteomesdifferentiateposttreatmentlymediseasefromchronicfatiguesyndrome AT athenaaschepmoes distinctcerebrospinalfluidproteomesdifferentiateposttreatmentlymediseasefromchronicfatiguesyndrome AT thereserclauss distinctcerebrospinalfluidproteomesdifferentiateposttreatmentlymediseasefromchronicfatiguesyndrome AT joshuanadkins distinctcerebrospinalfluidproteomesdifferentiateposttreatmentlymediseasefromchronicfatiguesyndrome AT davidgcamp distinctcerebrospinalfluidproteomesdifferentiateposttreatmentlymediseasefromchronicfatiguesyndrome AT bartkholland distinctcerebrospinalfluidproteomesdifferentiateposttreatmentlymediseasefromchronicfatiguesyndrome AT jonasbergquist distinctcerebrospinalfluidproteomesdifferentiateposttreatmentlymediseasefromchronicfatiguesyndrome AT patriciakcoyle distinctcerebrospinalfluidproteomesdifferentiateposttreatmentlymediseasefromchronicfatiguesyndrome AT richarddsmith distinctcerebrospinalfluidproteomesdifferentiateposttreatmentlymediseasefromchronicfatiguesyndrome AT brianafallon distinctcerebrospinalfluidproteomesdifferentiateposttreatmentlymediseasefromchronicfatiguesyndrome AT benjaminhnatelson distinctcerebrospinalfluidproteomesdifferentiateposttreatmentlymediseasefromchronicfatiguesyndrome |